Dr. Alessandro A. Castellarin

Jesse Berry is an Ophthalmologist in Los Angeles, California. Dr. Berry is rated as an Elite provider by MediFind in the treatment of Choroid Plexus Carcinoma. Her top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Cataract Removal. Dr. Berry is currently accepting new patients.

David Boyer is an Ophthalmologist in Encino, California. Dr. Boyer is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Diabetic Retinopathy. Dr. Boyer is currently accepting new patients.

Dr. Dante J. Pieramici graduated with honors from the Johns Hopkins University School of Medicine and completed Ophthalmology Residency at the Wilmer Eye Institute. He receive vitreoretinal fellowship training at the Emory Eye Center in Atlanta Georgia. Dr. Pieramici has held full-time academic positions at the Yale University Eye Center and the Wilmer Eye Institute, where he served as the Assistant Chief of Service and Director of Ocular Trauma. Currently he is the Codirector of the California Retina Research Foundation, a partner of the California Retina Consultants, and Assistant Clinical Professor of Ophthalmology at the Doheny Eye Center in Southern California. Dr. Pieramici has published over 100 articles, 16 book chapters, and has edited 3 books on retinal diseases. He lectures nationally and internationally on retinal diseases and ocular trauma.Dr. Pieramici’s research interests have been varied, and include clinical and basic science projects aimed at better understanding of the underlying pathophysiology of ocular diseases, so as to improve treatments for patients with age-related macular degeneration, diabetic retinopathy, retinal vascular diseases, and severe ocular injuries. He has been a clinical investigator, principal investigator, or reading center investigator in numerous NIH and pharmaceutical company sponsored clinical trials. Dr Pieramici has helped in the development of new surgical techniques including limited macular translocation and 25-gauge (small incision) vitrectomy surgery. Currently he is involved in the development of new drug delivery techniques for various retinal vascular diseases.Dr. Pieramici has received the Achievement Award from the American Academy of Ophthalmology and Honor Award from the American Society of Retinal Specialists. He is a member of the American Academy of Ophthalmology, the Retina Society, the Macula Society, the American Society of Retinal Specialists, the Association for Research in Vision and Ophthalmology, the American Society of Ocular Trauma where he serves as Vice President, and the Pan-American Ophthalmologic Society amongst others. Dr Pieramici is a member of S.E.E International and regularly trains international ophthalmologists from undeserved areas.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients. Dr. Pieramici is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Diabetic Retinopathy, and Vitrectomy.